After positive research results were presented at the American College of Rheumatology Annual Scientific Meeting earlier this month, Roche announced this week that it has filed for FDA approval of a biologics license application for its drug tocilizumab (marketed as Actemra) for the treatment of signs and symptoms of RA. As Dr. Borigini explained... Read more
October 12, 2007 was World Arthritis Day and, while it has already come and gone, we think this is a great opportunity for our community members to discuss how Rheumatoid Arthritis affects their lives or the lives of a loved one. This year's theme was "Small Things Matter" and we encourage all of you to submit a SharePost describing... Read more
Science news outlets and bloggers have been abuzz discussing two studies recently published in the New England Journal of medicine. An international team of scientists from Sweden, Singapore and the U.S. has studied the entire human genome looking for the genes that cause RA. Their findings have confirmed the genes identified in previous studies,... Read more
I saw a posting this week that the Oklahoma Medical Research Foundation is seeking RA patients to participate in several drug studies. Anyone interested in participating may call the Clinical Pharmacy Research Program at 271-7805 or email clinic@omrf.org. No deadline for participation was given in the news alert.
On April 12th, a Food and Drug Administration, FDA, advisory panel of experts rejected Merck’s drug, Arcoxia, in a 20-1 vote. It is a non-binding recommendation that the FDA should not approve the drug for the U.S. market. The FDA will be taken as advice and one factor to consider when the FDA is makes its decision whether or not to... Read more